Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	71.14	31.63	18.48
Graham Fair Price	49.14	3032.03	2032.94
PEG	-95.08	0.05	-0.97
Price/Book	22.38	0.77	0.63
Price/Cash Flow	-42.11	26.35	45.52
Prices/Earnings	-42.23	5.57	9.65
Price/Sales	33.93	1.24	0.92
Price/FCF	-42.11	26.35	45.52
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-1.72	0.16	0.16
Operating Margin	-54.41	0.01	0.03
ROA	115.05	0.02	< 0.005
ROE	0.02	0.03	111.85
ROIC	0.01	< 0.005	-56.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-396.17
Dividends QOQ	-0.96	-0.67	30.67
EBIT QOQ	-0.15	-0.57	-270.72
EPS QOQ	-0.10	1.17	1073.58
FCF QOQ	1.57	1.17	-25.79
Revenue QOQ	< 0.005	-0.06	-1367.56
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.88	43.59	9.30
Days Sales Outstanding (DSO)	53.74	56.81	5.72
Inventory Turnover	2.26	2.06	-8.51
Debt/Capitalization	0.21	0.19	-7.71
Quick Ratio	0.90	0.98	8.85
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3353.24	3436.01	2.47
Cash	229.31	429.55	87.32
Capex	-96.96	-46.46	52.08
Free Cash Flow	46.44	100.60	116.61
Revenue	2291.91	2145.91	-6.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.44	1.48	3.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.35	4.52	4.04
Naive Interpretation	Member

06 - Financial Health · Weak

Rating